Media desktop
Media tablet
Media mobile

High Potency Probiotics, Backed by Science.

Research and clinical studies support the success of our results-driven formula.
Order Now

Visbiome is the MOST STUDIED multi-strain probiotic available

Visbiome's unique proprietary formulation has been the subject of OVER 100 Clinical Studies since it's invention in the late 90s.

The Science Behind Your Gut

The Critical Nature of Research

The human gastrointestinal (Gl) tract is home to trillions of organisms which form the complex bacterial community known as the gut microbiome.

Probiotics may increasingly be a key factor in protecting this intricate network from the disastrous effects of disease. However, formulas vary. Successes will ultimately depend on the specific bacterial strains utilized, the concentration of bacteria, the way in which strains are processed, and the quality of the strains used.

Clinical studies

A Probiotic with Proven Relief

Our formulation has had numerous clinical studies proving its efficacy in the management of dysbiosis associated with the following conditions:

Dietary Management of Number of Studies As a medical food the formulation has been associated with:

Irritable Bowel Syndrome (IBS)

10

ref 1-10
  • Reductions in bloating, flatulence, and abdominal pain
  • Reductions in gut permeability

Ulcerative Colitis

8

ref 11-18
  • Improvements in UC Activity Index Scores
  • Reductions in frequency

Antibiotic Associated Diarrhea

1

ref 19
  • Reductions in antibiotic side effect

lleal Pouch Management

4

ref 20-23
  • Decreased bowel frequency

  1. 1 Kim et al. Neurogastroenterol Motil (2005) 17,1-10
  2. 2 Kim et al. Alimentary Pharmacology Therapeutics 2003; 17:895-904
  3. 3 Wong et al. Digestive Diseases and Sciences. 2014
  4. 4 Bazzocchi et al. Digestive and Liver Diseases 2002; 34(2):S48-53.
  5. 5 Guandalini et al. Journal of Pediatric Gastroenterology and Nutrition. 2010;51:24-30
  6. 6 Staudacher et al. Gastroenterology 2017;153:936-947
  7. 7 Ng S.C., et al. Journal of Gastroenterology and Hepatology 2013; 28(10):1624-31. doi: 10.1111 jgh. 12306
  8. 8 Boonma et al. Frontiers in Pain Research. 2021
  9. 9 Kim SE, et al. Journal of Neurogastroenterol Motility. 2015 Jan 1, 21 111-20.
  10. 10 Michail S, Kenche H. Probiotics Antimicro. Prot. 2011 3:1-7.
  11. 11 Bibiloni et al. American Journal of Gastroenterology. 2005;100:1539-1546
  12. 12 Tursi A, et al. Med Sci Monit. 2004;10:126-131. from Visbiome.com
  13. 13 Huynh Hien Q, et al. Inflamm Bowel Dis 15: 760-768 (2009)
  14. 14 Sood et al. Clinical Gastroenterology and Hepatology 2009;7:1202-1209
  15. 15 Tursi A. et al. Am J Gastroenterol. 105:2218-27 (2010)
  16. 16 Lee J., Moon G., et al. Korean J Gastroenterol Vol. 60 n. 2 94-101 (2012)
  17. 17 Ng SC, et al. Inflamm Bowel Dis. 2010;16:1286–1298.
  18. 18 Miele E, et al. American Journal of Gastroenterology. 2009;104:437–443.
  19. 19 C.P. Selinger et al. Journal of Hospital Infection 2013 Jun;84(2):159-65.
  20. 20 Gionchetti P, et al. Gastroenterology. 2000;119(2):305-309.
  21. 21 Gionchetti P, et al. Gastroenterology. 2003b;124(5):1202-1209.
  22. 22 Mimura T, et al. Gut. 2004;53(1):108 114.
  23. 23 Pronio, et al. Inflamm Bowel Dis 2008;14:662–668

Have More Questions About Our Products or Company?

Our team is happy to help, we try our best to respond to calls and emails within 24hrs.
Contact Us